Abstract
The neurotrophin family is comprised of the structurally related secreted proteins nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neurotrophine-4 (NT-4). They bind and activate the tyrosine kinase receptors Trk A, B, and C in a ligand-specific manner and additionally bind a shared p75NTR receptor. The neurotrophins were originally defined by their ability to support the survival and maturation of embryonic neurons. However, they also control important physiological functions of the adult nervous system including learning and memory, sensation, and energy homeostasis. For example, NGF/trkA signaling is critical for normal and pathological sensation of pain. Likewise, the BDNF/trkB pathway controls feeding and metabolism, and its dysfunction leads to severe obesity. Antibodies can modulate neurotrophin signaling. Thus, NGF blocking agents can attenuate pain in several animal models, and a recombinant humanized NGF blocking antibody (Tanezumab) has shown promising results in human clinical trials for osteoarthritic pain. On the other hand trkB agonist antibodies can modulate food intake and body weight in rodents and nonhuman primates. The power of monoclonal antibodies to modulate neurotrophin signaling promises to turn the rich biological insights into novel human medicines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aloe L, Tuveri MA, Carcassi U, Levi-Montalcini R (1992a) Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 35:351–355
Aloe L, Tuveri MA, Levi-Montalcini R (1992b) Nerve growth factor and distribution of mast cells in the synovium of adult rats. Clin Exp Rheumatol 10:203–204
Aloe L, Tuveri MA, Levi-Montalcini R (1992c) Studies on carrageenan-induced arthritis in adult rats: presence of nerve growth factor and role of sympathetic innervation. Rheumatol Int 12:213–216
Aloe L, Probert L, Kollias G, Bracci-Laudiero L, Spillantini MG, Levi-Montalcini R (1993) The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor. Growth Factors 9:149–155
ALS CNTF Treatment Study (ACTS) Phase I-II Study Group (1995) The pharmacokinetics of subcutaneaously administered recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis: relation to parameters of the acute-phase response. Clin Neuropharmacol 18:500–514
Banik RK, Subieta AR, Wu C, Brennan TJ (2005) Increased nerve growth factor after rat plantar incision contributes to guarding behavior and heat hyperalgesia. Pain 117:68–76
Barbacid M (1994) The Trk family of neurotrophin receptors. J Neurobiol 25:1386–1403
Barde YA, Edgar D, Thoenen H (1982) Purification of a new neurotrophic factor from mammalian brain. EMBO J 1:549–553
Barde YA, Davies AM, Johnson JE, Lindsay RM, Thoenen H (1987) Brain derived neurotrophic factor. Prog Brain Res 71:185–189
Bariohay B, Roux J, Tardivel C, Trouslard J, Jean A, Lebrun B (2009) Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology 150:2646–2653
Baydyuk M, Nguyen MT, Xu B (2011) Chronic deprivation of TrkB signaling leads to selective late-onset nigrostriatal dopaminergic degeneration. Exp Neurol 228:118–125
Bennett DL, Koltzenburg M, Priestley JV, Shelton DL, McMahon SB (1998) Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur J Neurosci 10:1282–1291
Berkemeier LR, Winslow JW, Kaplan DR, Nikolics K, Goeddel DV, Rosenthal A (1991) Neurotrophin-5: a novel neurotrophic factor that activates trk and trkB. Neuron 7:857–866
Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Muller FJ et al (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106:13594–13599
Boado RJ, Hui EK, Lu JZ, Pardridge WM (2010) Drug targeting of erythropoietin across the primate blood-brain barrier with an IgG molecular Trojan horse. J Pharmacol Exp Ther 333:961–969
Casadevall N, Eckardt KU, Rossert J (2005) Epoetin-induced autoimmune pure red cell aplasia. J Am Soc Nephrol 16(Suppl 1):S67–S69
Chang Q, Khare G, Dani V, Nelson S, Jaenisch R (2006) The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Neuron 49:341–348
Chao MV (1994) The p75 neurotrophin receptor. J Neurobiol 25:1373–1385
Chao MV, Rajagopal R, Lee FS (2006) Neurotrophin signalling in health and disease. Clin Sci (Lond) 110:167–173
Chong BH, Ho SJ (2005) Autoimmune thrombocytopenia. J Thromb Haemost 3:1763–1772
Cohen S, Levi-Montalcini R (1956) A nerve growth-stimulating factor isolated from snake venom. Proc Natl Acad Sci U S A 42:571–574
Cohen S, Levi-Montalcini R, Hamburger V (1954) A nerve growth-stimulating factor isolated from sarcom as 37 and 180. Proc Natl Acad Sci U S A 40:1014–1018
Conover JC, Yancopoulos GD (1997) Neurotrophin regulation of the developing nervous system: analyses of knockout mice. Rev Neurosci 8:13–27
Conover JC, Erickson JT, Katz DM, Bianchi LM, Poueymirou WT et al (1995) Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature 375:235–238
Cordeira JW, Frank L, Sena-Esteves M, Pothos EN, Rios M (2010) Brain-derived neurotrophic factor regulates hedonic feeding by acting on the mesolimbic dopamine system. J Neurosci 30:2533–2541
Cordon-Cardo C, Tapley P, Jing SQ, Nanduri V, O’Rourke E et al (1991) The trk tyrosine protein kinase mediates the mitogenic properties of nerve growth factor and neurotrophin-3. Cell 66:173–183
Cosgaya JM, Chan JR, Shooter EM (2002) The neurotrophin receptor p75NTR as a positive modulator of myelination. Science 298:1245–1248
Crowley C, Spencer SD, Nishimura MC, Chen KS, Pitts-Meek S et al (1994) Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76:1001–1011
Davies AM, Thoenen H, Barde YA (1986) The response of chick sensory neurons to brain-derived neurotrophic factor. J Neurosci 6:1897–1904
Davies AM, Horton A, Burton LE, Schmelzer C, Vandlen R, Rosenthal A (1993) Neurotrophin-4/5 is a mammalian-specific survival factor for distinct populations of sensory neurons. J Neurosci 13:4961–4967
DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci U S A 98:8850–8855
Dmitrieva N, Shelton D, Rice AS, McMahon SB (1997) The role of nerve growth factor in a model of visceral inflammation. Neuroscience 78:449–459
Duan W, Guo Z, Jiang H, Ware M, Mattson MP (2003) Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 144:2446–2453
Dyck PJ, Peroutka S, Rask C, Burton E, Baker MK et al (1997) Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology 48:501–505
Erickson JT, Conover JC, Borday V, Champagnat J, Barbacid M et al (1996) Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing. J Neurosci 16:5361–5371
Friedel RH, Schnurch H, Stubbusch J, Barde YA (1997) Identification of genes differentially expressed by nerve growth factor- and neurotrophin-3-dependent sensory neurons. Proc Natl Acad Sci U S A 94:12670–12675
Friess H, Zhu ZW, di Mola FF, Kulli C, Graber HU et al (1999) Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 230:615–624
Gao G, Lebherz C, Weiner DJ, Grant R, Calcedo R et al (2004) Erythropoietin gene therapy leads to autoimmune anemia in macaques. Blood 103:3300–3302
Garber K (2011) Fate of novel painkiller mAbs hangs in balance. Nat Biotechnol 29:173–174
Ghilardi JR, Freeman KT, Jimenez-Andrade JM, Mantyh WG, Bloom AP et al (2010) Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain. Mol Pain 6:87
Ghilardi JR, Freeman KT, Jimenez-Andrade JM, Mantyh WG, Bloom AP et al (2011) Sustained blockade of neurotrophin receptors TrkA, TrkB and TrkC reduces non-malignant skeletal pain but not the maintenance of sensory and sympathetic nerve fibers. Bone 48(2):389–398
Gorin PD, Johnson EM Jr (1980) Effects of long-term nerve growth factor deprivation on the nervous system of the adult rat: an experimental autoimmune approach. Brain Res 198:27–42
Gray J, Yeo G, Hung C, Keogh J, Clayton P et al (2007) Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity. Int J Obes (Lond) 31:359–364
Halvorson KG, Kubota K, Sevcik MA, Lindsay TH, Sotillo JE et al (2005) A blocking antibody to nerve growth factor attenuates skeletal pain induced by prostate tumor cells growing in bone. Cancer Res 65:9426–9435
Han JC, Liu QR, Jones M, Levinn RL, Menzie CM et al (2008) Brain-derived neurotrophic factor and obesity in the WAGR syndrome. N Engl J Med 359:918–927
Han JC, Muehlbauer MJ, Cui HN, Newgard CB, Haqq AM (2010) Lower brain-derived neurotrophic factor in patients with Prader-Willi syndrome compared to obese and lean control subjects. J Clin Endocrinol Metab 95:3532–3536
Hanyu O, Yamatani K, Ikarashi T, Soda S, Maruyama S et al (2003) Brain-derived neurotrophic factor modulates glucagon secretion from pancreatic alpha cells: its contribution to glucose metabolism. Diabetes Obes Metab 5:27–37
Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K et al (1993) Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363:266–270
Hohn A, Leibrock J, Bailey K, Barde YA (1990) Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344:339–341
Hovland DN Jr, Boyd RB, Butt MT, Engelhardt JA, Moxness MS et al (2007) Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF) in rhesus monkeys. Toxicol Pathol 35:676–692
Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677–736
Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD et al (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230–232
Hynes MA, Poulsen K, Armanini M, Berkemeier L, Phillips H, Rosenthal A (1994) Neurotrophin-4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures. J Neurosci Res 37:144–154
Ibanez CF, Ernfors P, Timmusk T, Ip NY, Arenas E et al (1993) Neurotrophin-4 is a target-derived neurotrophic factor for neurons of the trigeminal ganglion. Development 117:1345–1353
Ip NY, Stitt TN, Tapley P, Klein R, Glass DJ et al (1993) Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and nonneuronal cells. Neuron 10:137–149
Jimenez-Andrade JM, Martin CD, Koewler NJ, Freeman KT, Sullivan LJ et al (2007) Nerve growth factor sequestering therapy attenuates non-malignant skeletal pain following fracture. Pain 133:183–196
Jimenez-Andrade JM, Bloom AP, Stake JI, Mantyh WG, Taylor RN et al (2010) Pathological sprouting of adult nociceptors in chronic prostate cancer-induced bone pain. J Neurosci 30:14649–14656
Johnson EM Jr, Yip HK (1985) Central nervous system and peripheral nerve growth factor provide trophic support critical to mature sensory neuronal survival. Nature 314:751–752
Johnson EM Jr, Gorin PD, Brandeis LD, Pearson J (1980) Dorsal root ganglion neurons are destroyed by exposure in utero to maternal antibody to nerve growth factor. Science 210:916–918
Kalcheim C, Barde YA, Thoenen H, Le Douarin NM (1987) In vivo effect of brain-derived neurotrophic factor on the survival of developing dorsal root ganglion cells. EMBO J 6:2871–2873
Kalcheim C, Carmeli C, Rosenthal A (1992) Neurotrophin 3 is a mitogen for cultured neural crest cells. Proc Natl Acad Sci U S A 89:1661–1665
Kells AP, Fong DM, Dragunow M, During MJ, Young D, Connor B (2004) AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease. Mol Ther 9:682–688
Kernie SG, Liebl DJ, Parada LF (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19:1290–1300
Klein R, Jing SQ, Nanduri V, O’Rourke E, Barbacid M (1991a) The trk proto-oncogene encodes a receptor for nerve growth factor. Cell 65:189–197
Klein R, Nanduri V, Jing SA, Lamballe F, Tapley P et al (1991b) The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell 66:395–403
Klein R, Lamballe F, Bryant S, Barbacid M (1992) The trkB tyrosine protein kinase is a receptor for neurotrophin-4. Neuron 8:947–956
Kline DD, Ogier M, Kunze DL, Katz DM (2010) Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice. J Neurosci 30:5303–5310
Knusel B, Beck KD, Winslow JW, Rosenthal A, Burton LE et al (1992) Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain. J Neurosci 12:4391–4402
Koewler NJ, Freeman KT, Buus RJ, Herrera MB, Jimenez-Andrade JM et al (2007) Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur. J Bone Miner Res 22:1732–1742
Koliatsos VE, Cayouette MH, Berkemeier LR, Clatterbuck RE, Price DL, Rosenthal A (1994) Neurotrophin 4/5 is a trophic factor for mammalian facial motor neurons. Proc Natl Acad Sci U S A 91:3304–3308
Lamballe F, Klein R, Barbacid M (1991) trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66:967–979
Lane NE, Schnitzer TJ, Birbara CA, Mokhtarani M, Shelton DL et al (2010) Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med 363:1521–1531
Lang AE, Gill S, Patel NK, Lozano A, Nutt JG et al (2006) Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 59:459–466
Levi-Montalcini R (1964) Growth control of nerve cells by a protein factor and its antiserum: discovery of this factor may provide new leads to understanding of some neurogenetic processes. Science 143:105–110
Levi-Montalcini R, Aloe L (1985) Differentiating effects of murine nerve growth factor in the peripheral and central nervous systems of Xenopus laevis tadpoles. Proc Natl Acad Sci U S A 82:7111–7115
Levi-Montalcini R, Hamburger V (1951) Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 116:321–361
Lewin GR, Mendell LM (1993) Nerve growth factor and nociception. Trends Neurosci 16:353–359
Lewin GR, Ritter AM, Mendell LM (1993) Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci 13:2136–2148
Lin JC, Tsao D, Barras P, Bastarrachea RA, Boyd B et al (2008) Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates. PLoS One 3:e1900
Lindsay RM, Harmar AJ (1989) Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337:362–364
Lindsay RM, Barde YA, Davies AM, Rohrer H (1985) Differences and similarities in the neurotrophic growth factor requirements of sensory neurons derived from neural crest and neural placode. J Cell Sci Suppl 3:115–129
Liu X, Ernfors P, Wu H, Jaenisch R (1995) Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 375:238–241
Lowe EM, Anand P, Terenghi G, Williams-Chestnut RE, Sinicropi DV, Osborne JL (1997) Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol 79:572–577
Luther JA, Birren SJ (2009) p75 and TrkA signaling regulates sympathetic neuronal firing patterns via differential modulation of voltage-gated currents. J Neurosci 29:5411–5424
Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW et al (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96:15239–15244
Maisonpierre PC, Belluscio L, Squinto S, Ip NY, Furth ME et al (1990) Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science 247:1446–1451
Mantyh WG, Jimenez-Andrade JM, Stake JI, Bloom AP, Kaczmarska MJ et al (2010) Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain. Neuroscience 171:588–598
Massa SM, Yang T, Xie Y, Shi J, Bilgen M et al (2010) Small molecule BDNF mimetics activate TrkB signaling and prevent neuronal degeneration in rodents. J Clin Invest 120:1774–1785
McMahon SB, Bennett DL, Priestley JV, Shelton DL (1995) The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med 1:774–780
Moro K, Shiotani A, Watabe K, Takeda Y, Saito K et al (2006) Adenoviral gene transfer of BDNF and GDNF synergistically prevent motoneuron loss in the nucleus ambiguus. Brain Res 1076:1–8
Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE et al (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer’s disease. Nat Med 15:331–337
Nakagawa T, Tsuchida A, Itakura Y, Nonomura T, Ono M et al (2000) Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 49:436–444
Ng MC, Tam CH, So WY, Ho JS, Chan AW et al (2010) Implication of genetic variants near NEGR1, SEC16B, TMEM18, ETV5/DGKG, GNPDA2, LIN7C/BDNF, MTCH2, BCDIN3D/FAIM2, SH2B1, FTO, MC4R, and KCTD15 with obesity and type 2 diabetes in 7705 Chinese. J Clin Endocrinol Metab 95:2418–2425
Nguyen CB, Harris L, Szonyi E, Baughman SA, Hale VG et al (2000) Tissue disposition and pharmacokinetics of recombinant human nerve growth factor after acute and chronic subcutaneous administration in monkeys. Drug Metab Dispos 28:598–607
Nicholson JR, Peter JC, Lecourt AC, Barde YA, Hofbauer KG (2007) Melanocortin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J Neuroendocrinol 19:974–982
Ono M, Ichihara J, Nonomura T, Itakura Y, Taiji M et al (1997) Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice. Biochem Biophys Res Commun 238:633–637
Ono M, Itakura Y, Nonomura T, Nakagawa T, Nakayama C et al (2000) Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 49:129–133
Patapoutian A, Reichardt LF (2001) Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272–280
Pinco O, Carmeli C, Rosenthal A, Kalcheim C (1993) Neurotrophin-3 affects proliferation and differentiation of distinct neural crest cells and is present in the early neural tube of avian embryos. J Neurobiol 24:1626–1641
Rios M, Fan G, Fekete C, Kelly J, Bates B et al (2001) Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 15:1748–1757
Ro LS, Chen ST, Tang LM, Jacobs JM (1999) Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain 79:265–274
Rosenthal A, Goeddel DV, Nguyen T, Lewis M, Shih A et al (1990) Primary structure and biological activity of a novel human neurotrophic factor. Neuron 4:767–773
Rosenthal A, Goeddel DV, Nguyen T, Martin E, Burton LE et al (1991) Primary structure and biological activity of human brain-derived neurotrophic factor. Endocrinology 129:1289–1294
Sahenk Z, Nagaraja HN, McCracken BS, King WM, Freimer ML et al (2005) NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology 65:681–689
Sahenk Z, Galloway G, Edwards C, Malik V, Kaspar BK et al (2010) TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice. Exp Neurol 224:495–506
Schecterson LC, Bothwell M (2010) Neurotrophin receptors: old friends with new partners. Dev Neurobiol 70:332–338
Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA (1992) Brain-derived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 360:757–759
Sevcik MA, Ghilardi JR, Peters CM, Lindsay TH, Halvorson KG et al (2005) Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 115:128–141
Sharma N, Deppmann CD, Harrington AW, St Hillaire C, Chen ZY et al (2010) Long-distance control of synapse assembly by target-derived NGF. Neuron 67:422–434
Shelton DL, Zeller J, Ho WH, Pons J, Rosenthal A (2005) Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain 116:8–16
Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S et al (1994) Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk/NGF receptor gene. Nature 368:246–249
Sun M, Kong L, Wang X, Lu XG, Gao Q, Geller AI (2005) Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson’s disease. Brain Res 1052:119–129
Svensson P, Cairns BE, Wang K, Arendt-Nielsen L (2003) Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia. Pain 104:241–247
Teillon S, Calderon GA, Rios M (2010) Diminished diet-induced hyperglycemia and dyslipidemia and enhanced expression of PPARalpha and FGF21 in mice with hepatic ablation of brain-derived neurotropic factor. J Endocrinol 205:37–47
Thorleifsson G, Walters GB, Gudbjartsson DF, Steinthorsdottir V, Sulem P et al (2009) Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat Genet 41:18–24
Toma H, Winston J, Micci MA, Shenoy M, Pasricha PJ (2000) Nerve growth factor expression is up-regulated in the rat model of L-arginine-induced acute pancreatitis. Gastroenterology 119:1373–1381
Tonra JR, Ono M, Liu X, Garcia K, Jackson C et al (1999) Brain-derived neurotrophic factor improves blood glucose control and alleviates fasting hyperglycemia in C57BLKS-Lepr(db)/lepr(db) mice. Diabetes 48:588–594
Tsao D, Thomsen HK, Chou J, Stratton J, Hagen M et al (2008) TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology 149:1038–1048
Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, Ogawa W et al (2001) The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia 44:555–566
Unger TJ, Calderon GA, Bradley LC, Sena-Esteves M, Rios M (2007) Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. J Neurosci 27:14265–14274
Wild KD, Bian D, Zhu D, Davis J, Bannon AW et al (2007) Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance. J Pharmacol Exp Ther 322:282–287
Winston J, Toma H, Shenoy M, Pasricha PJ (2001) Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain 89:181–186
Wood JN (2010) Nerve growth factor and pain. N Engl J Med 363:1572–1573
Wu C, Erickson MA, Xu J, Wild KD, Brennan TJ (2009) Expression profile of nerve growth factor after muscle incision in the rat. Anesthesiology 110:140–149
Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington’s disease phenotypes in YAC128 mice. J Neurosci 30:14708–14718
Xu B, Goulding EH, Zang K, Cepoi D, Cone RD et al (2003) Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat Neurosci 6:736–742
Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J et al (2004) A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 7:1187–1189
Yip HK, Rich KM, Lampe PA, Johnson EM Jr (1984) The effects of nerve growth factor and its antiserum on the postnatal development and survival after injury of sensory neurons in rat dorsal root ganglia. J Neurosci 4:2986–2992
Zahn PK, Subieta A, Park SS, Brennan TJ (2004) Effect of blockade of nerve growth factor and tumor necrosis factor on pain behaviors after plantar incision. J Pain 5:157–163
Zhang X, Huang J, McNaughton PA (2005) NGF rapidly increases membrane expression of TRPV1 heat-gated ion channels. EMBO J 24:4211–4223
Zhou QH, Fu A, Boado RJ, Hui EK, Lu JZ, Pardridge WM (2011) Receptor-mediated abeta amyloid antibody targeting to Alzheimer’s disease mouse brain. Mol Pharm 8:280–285
Zhu Z, Friess H, diMola FF, Zimmermann A, Graber HU et al (1999) Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J Clin Oncol 17:2419–2428
Zuccato C, Cattaneo E (2009) Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 5:311–322
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg 2014
About this chapter
Cite this chapter
Rosenthal, A., Lin, J.C. (2014). Modulation of Neurotrophin Signaling by Monoclonal Antibodies. In: Lewin, G., Carter, B. (eds) Neurotrophic Factors. Handbook of Experimental Pharmacology, vol 220. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45106-5_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-45106-5_19
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45105-8
Online ISBN: 978-3-642-45106-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)